Michael Weiss, MD, PhD, MBA
Indiana University School of Medicine, Indianapolis, Indiana

Dr. Michael A. Weiss is a Distinguished Professor at Indiana University and the Robert A. Harris Professor of Biochemistry & Molecular Biology and Department Chair. He is also an Adjunct Professor of Chemistry at IU-Bloomington and Professor of Biomedical Engineering by Courtesy at Purdue. Dr. Weiss’ research lies in molecular endocrinology, focusing on the folding and function of insulin with application to diabetes mellitus. Dr. Weiss is a graduate of Harvard College, the Harvard-MIT Program in Health Sciences & Technology (HST) and M.D.-Ph.D. Program at Harvard Medical School. With clinical training at the Brigham & Women’s Hospital, he is Board Certified in Internal Medicine. Holding >20 issued or pending patents in insulin technologies, Dr. Weiss is a founder and Chief Innovation Officer of Thermalin, Inc. Following Ph.D. research under Prof. Martin Karplus (Harvard Department of Chemistry & Chemical Biology) and clinical training, Dr. Weiss joined the Endocrine Unit at the Massachusetts General Hospital (1988-1994). He was a member of the junior faculty of the Department of Biological Chemistry & Molecular Pharmacology at Harvard Medical School (1988-1994), Professor at the University of Chicago in both the Divisions of Biological and Physical Sciences (1994-1999), and Cowan-Blum Professor of Biochemistry and Department Chair at the Case Western Reserve University School of Medicine (1999-2017). Dr. Weiss is a past chair of the NIDDK Board of Scientific Counselors at the National Institutes of Health.